GENEWIZ launches Gene Synthesis 2.0 to accelerate custom gene design and production
New Sprint, Flex, and Flex+ packages deliver faster turnaround times, expanded vector options, and advanced codon optimization through a modern digital ordering experience
11 May 2026Product news
GENEWIZ from Azenta Life Sciences, has launched Gene Synthesis 2.0. This updated service platform simplifies how researchers design and order genes, reducing complexity while accelerating time from sequence to experiment.
Streamlined gene synthesis ordering with Sprint, Flex, and Flex+ packages
Gene Synthesis 2.0 is organized around three flexible packages: Sprint, Flex, and Flex+. The platform introduces a streamlined, intuitive ordering experience that enables researchers to design cloning strategies, select vectors, assess sequence complexity, and place orders in minutes.
The online interface provides real-time visibility into pricing and turnaround time, helping scientists choose the most suitable package for their project needs. This structure is designed to support a wide range of applications in synthetic biology, including antibody discovery, AI-enabled biology, and gene and cell therapy.
Advanced codon optimization powered by machine learning
Gene Synthesis 2.0 features an upgraded codon optimization capability that combines established heuristic approaches with machine-learning models trained on high-expression datasets. This integrated approach is designed to improve expression reliability across a broad range of organisms and sequence architectures.
While leveraging advanced algorithms, the platform maintains customer control over design choices, allowing researchers to tailor codon optimization parameters to their specific experimental requirements.
Live demonstrations at PEGS and ASGCT in Boston
The capabilities of Gene Synthesis 2.0 are being highlighted at PEGS (booth #24) and the American Society of Gene and Cell Therapy (ASGCT) annual meeting (booth #915), both held May 11–15. Attendees can experience a live demonstration of the new ordering platform and explore how the Sprint, Flex, and Flex+ packages support diverse gene synthesis projects.
Support for scalable synthetic biology and gene therapy programs
To further reduce friction for teams scaling their research, Gene Synthesis 2.0 includes complimentary custom vector onboarding and secure storage of deliverables for up to two years. These features are designed to support long-term, multi-phase projects in areas such as synthetic biology, biologics development, and gene and cell therapy.
Gene Synthesis 2.0 is supported by a global infrastructure that includes more than 70 PhD-level scientists providing real-time support across more than 10 time zones for project consultation and project updates. With over 2,600 sample drop and delivery boxes worldwide, researchers can access GENEWIZ services and initiate projects with minimal logistical barriers.
Focus on speed, clarity, and reliability for modern research
Across all packages, customers benefit from transparent pricing, predictable turnaround times, and the consistency associated with GENEWIZ, which reports a historical project success rate of 99.8 percent.
“Gene Synthesis 2.0 reflects how researchers work today — where speed, clarity, and reliability matter at every step,” said Trey Martin, President of GENEWIZ from Azenta Life Sciences. “By simplifying the path from sequence design to execution, this offering helps scientists move faster in rapidly evolving fields such as antibody discovery, AI-enabled biology, and gene and cell therapy.”
Want the latest science news straight to your inbox? Become a SelectScience member for free today>>
Frequently asked questions
What is Gene Synthesis 2.0 from GENEWIZ by Azenta Life Sciences and how does it support synthetic biology, antibody discovery, and gene and cell therapy?
Gene Synthesis 2.0 is an updated gene synthesis service platform from GENEWIZ, part of Azenta Life Sciences, designed to simplify how researchers design and order genes. It streamlines the path from sequence design to experiment by offering an intuitive online ordering interface with real-time visibility into pricing and turnaround times.
Organized into Sprint, Flex, and Flex+ packages, the platform supports a wide range of synthetic biology applications, including antibody discovery, AI-enabled biology, and gene and cell therapy, by reducing complexity, accelerating project timelines, and providing transparent, predictable service.
How do the Sprint, Flex, and Flex+ packages in Gene Synthesis 2.0 improve the gene synthesis ordering experience for modern research programs?
The Sprint, Flex, and Flex+ packages in Gene Synthesis 2.0 provide a structured yet flexible framework for gene synthesis projects. Through a streamlined online interface, researchers can design cloning strategies, select vectors, assess sequence complexity, and place orders within minutes. The platform displays real-time pricing and turnaround information, enabling scientists to choose the most suitable package for their specific project needs.
Across all packages, customers benefit from transparent pricing, predictable turnaround times, and a reported historical project success rate of 99.8%, supporting efficient planning and execution of modern research programs.
How does Gene Synthesis 2.0 use machine learning–powered codon optimization and global infrastructure to enhance reliability and scalability for gene and cell therapy and other multiomics projects?
Gene Synthesis 2.0 incorporates advanced codon optimization that combines established heuristic methods with machine-learning models trained on high-expression datasets. This integrated approach is designed to improve expression reliability across diverse organisms and sequence architectures, while still allowing researchers to control and tailor codon optimization parameters to their experimental requirements.
To support scalable programs in areas such as synthetic biology, biologics development, and gene and cell therapy, the platform also offers complimentary custom vector onboarding, secure storage of deliverables for up to two years, and access to a global infrastructure of more than 70 PhD-level scientists across over 10 time zones, along with more than 2,600 sample drop and delivery boxes worldwide.